Goeltz II Robert C. 4
4 · Arcus Biosciences, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-23+86,600→ 86,600 totalExercise: $15.44Exp: 2034-01-22→ Common Stock (86,600 underlying) - Award
Common Stock
2024-01-23+21,300→ 73,131 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.